Results 171 to 180 of about 14,206 (239)

Direct trapping of the transport-segment DNA by the central domain of type IIA topoisomerases. [PDF]

Sci Adv
Xin Y, Xian R, Liu C, Zhang O, Rao Z, Li X, Chen Y.   +6 more
europepmc   +1 more source

Identification of a <i>TOP3A</i> genetic variant as a novel biomarker for sensitivity to doxorubicin. [PDF]

Front Pharmacol
Takacova T, Schirmer MA.
europepmc   +1 more source

Gyrase and Topoisomerase IV as Antibacterial Targets for Gepotidacin and Zoliflodacin: Teaching Old Enzymes New Tricks. [PDF]

Int J Mol Sci
Osheroff N.
europepmc   +1 more source

Processing of DNA Topoisomerase II-DNA-Protein Crosslinks Associated With Anticancer Drugs. [PDF]

Genes Cells
Sakasai R, Iwabuchi K.
europepmc   +1 more source

Molecular Determinants of Response and Rational Drug Combinations for Antibody-Drug Conjugates (ADCs) with Topoisomerase I (TOP1) Inhibitor Payloads. [PDF]

J Mol Biol
Pommier Y.
europepmc   +1 more source

DNA topological regulation in RNA polymerase II transcription. [PDF]

Cell Mol Biol Lett
Bunch H.
europepmc   +1 more source

Involvement of DNA topoisomerases and DNA topoisomerase inhibitors in the induction of leukemia cell differentiation

Annals of Oncology, 1994
openaire   +2 more sources

Proteomic Analysis of Human Topoisomerases Reveals Their Distinct and Diverse Cellular Functions. [PDF]

Mol Cell Proteomics
Zhang H, Xiong Y, Chen Z, Chen J.
europepmc   +1 more source

Enzyme-DNA Interactions Affect the Catalytic Inhibition of Mycobacterial Gyrases by Antibacterial Drugs. [PDF]

ACS Infect Dis
Armenia JF, Osheroff N.
europepmc   +1 more source

DNA deformability in sequence-dependent capture of E. coli gyrase. [PDF]

Nat Commun
Baker ML, Johnson HR, Eckerty RA, Fogg JM, Summers SL, Vayssières M, Marechal N, Lamour V, Olson WK, Zechiedrich L.   +9 more
europepmc   +1 more source